<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Eli Lilly]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Eli Lilly on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=69253"/>
<item>
<title><![CDATA[FDA Probes 2 Deaths Possibly Related to Lilly Drug]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2013/06/18/lilly-investigates-two-unexplained-deaths-related-to-lilly-injection/?]]></link>
<guid>http://www.foxbusiness.com/industries/2013/06/18/lilly-investigates-two-unexplained-deaths-related-to-lilly-injection/</guid>
<pubDate><![CDATA[Tue, 18 Jun 2013 12:35:52 EDT]]></pubDate>
<description><![CDATA[U.S. safety regulators are investigating two 'unexplained' deaths that may be related to Eli Lilly’s Zyprexa injections, an antipsychotic drug.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/investing/eliLillyLab.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[FDA Investigating Two Deaths From Eli Lilly Injection]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2487202639001/fda-investigating-two-deaths-from-eli-lilly-injection/?]]></link>
<guid>http://video.foxbusiness.com/v/2487202639001/fda-investigating-two-deaths-from-eli-lilly-injection/</guid>
<pubDate><![CDATA[Tue, 18 Jun 2013 12:24:25 EDT]]></pubDate>
<description><![CDATA[FBN's Lori Rothman breaks down late-morning market news.]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/061813/640/360/061813_fb_brief11.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Pfizer to Spin Off Remaining Zoetis Stake]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/22/pfizer-to-spin-off-remaining-zoetis-stake/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/22/pfizer-to-spin-off-remaining-zoetis-stake/</guid>
<pubDate><![CDATA[Wed, 22 May 2013 09:15:09 EDT]]></pubDate>
<description><![CDATA[Pfizer Inc. (PFE) plans to split off its remaining interest in its former animal-medicine unit Zoetis Inc. (ZTS) through a voluntary exchange offer with its shareholders.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Analysis: Amazon gets help to lure big business to the cloud]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/15/analysis-amazon-gets-help-to-lure-big-business-to-cloud/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/15/analysis-amazon-gets-help-to-lure-big-business-to-cloud/</guid>
<pubDate><![CDATA[Wed, 15 May 2013 00:07:26 EDT]]></pubDate>
<description><![CDATA[As Amazon.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/feeds/Reuters/2013/05/15/2013-05-15T040726Z_1_CBRE94E0BGS00_3_TAX-AMAZON.JPG</media:thumbnail>
</item>
<item>
<title><![CDATA[Lilly CEO Recovering from Surgery for Dilated Aorta]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/14/lilly-ceo-recovering-from-surgery-for-dilated-aorta/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/14/lilly-ceo-recovering-from-surgery-for-dilated-aorta/</guid>
<pubDate><![CDATA[Tue, 14 May 2013 09:29:51 EDT]]></pubDate>
<description><![CDATA[Eli Lilly & Co. (LLY) said Chairman and Chief Executive John C. Lechleiter is recovering from Monday surgery for a dilated aorta.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eli Lilly Ends Development of Lymphoma Drug Enzastaurin; Missed Study Endpoint]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/eli-lilly-ends-development-lymphoma-drug-enzastaurin-missed-study-endpoint/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/eli-lilly-ends-development-lymphoma-drug-enzastaurin-missed-study-endpoint/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 08:58:07 EDT]]></pubDate>
<description><![CDATA[Eli Lilly & Co. (LLY) said it will stop developing enzastaurin because a late-stage study showed the drug didn't significantly increase the survival of patients with diffuse large B-cell lymphoma.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Lilly To Take $30M Charge After Disappointing Drug Trial]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2013/05/10/lilly-to-take-30m-charge-after-relapse-cancer-drug-disappoints-in-trial/?]]></link>
<guid>http://www.foxbusiness.com/industries/2013/05/10/lilly-to-take-30m-charge-after-relapse-cancer-drug-disappoints-in-trial/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 08:45:21 EDT]]></pubDate>
<description><![CDATA[Lilly's says it will take a $30 million charge in the second quarter as it stops developing a relapse cancer drug that failed to meet expectations in a late-stage study. ]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Lilly CEO to Have Artery Surgery, Seen Returning by Fall]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-to-have-artery-surgery-seen-returning-by-fall159306/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-to-have-artery-surgery-seen-returning-by-fall159306/</guid>
<pubDate><![CDATA[Mon, 06 May 2013 18:43:01 EDT]]></pubDate>
<description><![CDATA[Drug maker Eli Lilly & Co. (LLY) said Chairman and Chief Executive John C. Lechleiter will hand over his duties to others while he undergoes surgery to repair an enlarged artery and recovers for a few months.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Lilly CEO to Have Artery Surgery, Seen Returning By Fall]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-to-have-artery-surgery-seen-returning-by-fall787248/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-to-have-artery-surgery-seen-returning-by-fall787248/</guid>
<pubDate><![CDATA[Mon, 06 May 2013 18:25:04 EDT]]></pubDate>
<description><![CDATA[Drug maker Eli Lilly & Co. (LLY) said Chairman and Chief Executive John C. Lechleiter will hand over his duties to others while he undergoes surgery to repair an enlarged artery and recovers for a few months.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Lilly CEO to undergo surgery, CFO Rice to become interim CEO]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-to-undergo-surgery-cfo-rice-to-become-interim-ceo/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-to-undergo-surgery-cfo-rice-to-become-interim-ceo/</guid>
<pubDate><![CDATA[Mon, 06 May 2013 17:44:28 EDT]]></pubDate>
<description><![CDATA[Eli Lilly & Co's longtime Chief Executive John Lechleiter will undergo surgery next Monday for a dilated aorta, but is expected to make a full recovery from the potentially dangerous condition and return to work this summer, the drugmaker said on Monday.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/feeds/Reuters/2013/05/06/2013-05-06T214428Z_1_CBRE9451OEA00_3_APEC.JPG</media:thumbnail>
</item>
<item>
<title><![CDATA[Lilly CEO Lechleiter to undergo surgery for dilated aorta]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-lechleiter-to-undergo-surgery-for-dilated-aorta/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/06/lilly-ceo-lechleiter-to-undergo-surgery-for-dilated-aorta/</guid>
<pubDate><![CDATA[Mon, 06 May 2013 17:27:16 EDT]]></pubDate>
<description><![CDATA[Drug maker Eli Lilly and Co said Chief Executive John Lechleiter will undergo a surgery on May 13 to treat a dilated aorta but is expected to recover and return to work by this summer.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/feeds/Reuters/2013/05/06/2013-05-06T212716Z_1_CBRE9451NLI00_3_HEALTH-SUMMIT.JPG</media:thumbnail>
</item>
<item>
<title><![CDATA[Eli Lilly CEO to Undergo Surgery Next Week; Expected to Return to Duties Later This Summer]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/06/eli-lilly-ceo-to-undergo-surgery-next-week-expected-to-return-to-duties-later/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/06/eli-lilly-ceo-to-undergo-surgery-next-week-expected-to-return-to-duties-later/</guid>
<pubDate><![CDATA[Mon, 06 May 2013 17:04:55 EDT]]></pubDate>
<description><![CDATA[Eli Lilly & Co. (LLY) Chairman and Chief Executive John C. Lechleiter is scheduled to undergo surgery next week for a dilated aorta and is expected to make a full recovery and return to his duties later this summer.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:58:38 EDT]]></pubDate>
<description><![CDATA[Major drug makers are finding it more difficult than expected to overcome the blow of recent patent expirations, with Merck & Co. (MRK) becoming the second company after Pfizer Inc. (PFE) to report disappointing sales for the first quarter and lower its full-year outlook.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eli Lilly, P&G Surpass Earnings’ Estimates]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2323406821001/eli-lilly-pg-surpass-earnings-estimates/?]]></link>
<guid>http://video.foxbusiness.com/v/2323406821001/eli-lilly-pg-surpass-earnings-estimates/</guid>
<pubDate><![CDATA[Wed, 24 Apr 2013 09:24:08 EDT]]></pubDate>
<description><![CDATA[Earnings HQ: FBN’s Diane Macedo breaks down first-quarter earnings report.]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/042413/640/360/042413_Imus_PG.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Eli Lilly Profit Beats Expectations, Boosted by Lower Taxes]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2013/04/24/eli-lilly-profit-beats-expectations-boosted-by-lower-taxes/?]]></link>
<guid>http://www.foxbusiness.com/industries/2013/04/24/eli-lilly-profit-beats-expectations-boosted-by-lower-taxes/</guid>
<pubDate><![CDATA[Wed, 24 Apr 2013 08:16:05 EDT]]></pubDate>
<description><![CDATA[The company reported higher-than-expected quarterly earnings due to favorable taxes and cost controls, but sales missed expectations.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/U.S./081109_elc.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Eli Lilly, Wyndham Top Estimates]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2323445444001/eli-lilly-wyndham-top-estimates/?]]></link>
<guid>http://video.foxbusiness.com/v/2323445444001/eli-lilly-wyndham-top-estimates/</guid>
<pubDate><![CDATA[Wed, 24 Apr 2013 08:06:18 EDT]]></pubDate>
<description><![CDATA[Earnings HQ: FBN’s Diane Macedo breaks down first-quarter earnings reports.]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/042413/640/360/042413_Imus_LLY.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Eli Lilly 1st-Quarter Net Rose 53%]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/24/eli-lilly-1st-quarter-net-rose-53/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/24/eli-lilly-1st-quarter-net-rose-53/</guid>
<pubDate><![CDATA[Wed, 24 Apr 2013 07:35:02 EDT]]></pubDate>
<description><![CDATA[Eli Lilly & Co.'s (LLY) first-quarter earnings rose 53%, thanks in part to a gain from transferring some commercial rights, while margins improved despite flat revenue.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eli Lilly 1st-Quarter Net Rose 53% on Gain; Revenue Flat]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/24/eli-lilly-1st-quarter-net-rose-53-on-gain-revenue-flat/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/24/eli-lilly-1st-quarter-net-rose-53-on-gain-revenue-flat/</guid>
<pubDate><![CDATA[Wed, 24 Apr 2013 07:16:34 EDT]]></pubDate>
<description><![CDATA[Eli Lilly & Co.'s (LLY) first-quarter earnings rose 53%, thanks in part to a gain from transferring some commercial rights, while margins improved despite flat revenue.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Glaxo in Drug-Discovery Venture Capital Deal]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/22/glaxo-in-drug-discovery-venture-capital-deal/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/22/glaxo-in-drug-discovery-venture-capital-deal/</guid>
<pubDate><![CDATA[Mon, 22 Apr 2013 17:35:05 EDT]]></pubDate>
<description><![CDATA[GlaxoSmithKline PLC (GSK, GSK.LN) will partner with venture capitalists from San Diego in an unusual deal worth up to $495 million to start several drug-discovery firms over the next three years.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[WEEK AHEAD: Tech, Energy, Defense to Report Earnings Next Week]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/19/week-ahead-tech-energy-defense-to-report-earnings-next-week/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/19/week-ahead-tech-energy-defense-to-report-earnings-next-week/</guid>
<pubDate><![CDATA[Fri, 19 Apr 2013 15:44:48 EDT]]></pubDate>
<description><![CDATA[Next week brings a heavy calendar of quarterly results from some of the biggest tech and energy companies in the U.S. as earnings season heats up.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
